These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 26926380)

  • 41. Walking speed, rather than Expanded Disability Status Scale, relates to long-term patient-reported impact in progressive MS.
    Bosma L; Kragt JJ; Polman CH; Uitdehaag BM
    Mult Scler; 2013 Mar; 19(3):326-33. PubMed ID: 22907939
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis.
    Cadavid D; Cohen JA; Freedman MS; Goldman MD; Hartung HP; Havrdova E; Jeffery D; Kapoor R; Miller A; Sellebjerg F; Kinch D; Lee S; Shang S; Mikol D
    Mult Scler; 2017 Jan; 23(1):94-105. PubMed ID: 27003945
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Short-term impact of fampridine on motor and cognitive functions, mood and quality of life among multiple sclerosis patients.
    Pavsic K; Pelicon K; Ledinek AH; Sega S
    Clin Neurol Neurosurg; 2015 Dec; 139():35-40. PubMed ID: 26363365
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of the EDSS, Timed 25-Foot Walk, and the 9-Hole Peg Test as Clinical Trial Outcomes in Relapsing-Remitting Multiple Sclerosis.
    Koch MW; Mostert JP; Wolinsky JS; Lublin FD; Uitdehaag B; Cutter GR
    Neurology; 2021 Oct; 97(16):e1560-e1570. PubMed ID: 34433679
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plantarflexor weakness negatively impacts walking in persons with multiple sclerosis more than plantarflexor spasticity.
    Wagner JM; Kremer TR; Van Dillen LR; Naismith RT
    Arch Phys Med Rehabil; 2014 Jul; 95(7):1358-65. PubMed ID: 24582617
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical assessment of gait in individuals with multiple sclerosis using wearable inertial sensors: Comparison with patient-based measure.
    Pau M; Caggiari S; Mura A; Corona F; Leban B; Coghe G; Lorefice L; Marrosu MG; Cocco E
    Mult Scler Relat Disord; 2016 Nov; 10():187-191. PubMed ID: 27919488
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gait pattern changes after six-minute walk test in persons with multiple sclerosis.
    Escudero-Uribe S; Hochsprung A; Izquierdo-Ayuso G
    Physiother Res Int; 2019 Jan; 24(1):e1741. PubMed ID: 30192036
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Translation and validation of the multiple sclerosis walking scale 12 for the German population - the MSWS-12/D.
    Chorschew A; Kesgin F; Bellmann-Strobl J; Flachenecker P; Schiffmann I; Rosenthal F; Althoff P; Drebinger D; Arsenova R; Rasche L; Dorsch EM; Heesen C; Paul F; Stellmann JP; Schmitz-Hübsch T
    Health Qual Life Outcomes; 2023 Oct; 21(1):110. PubMed ID: 37814258
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exploratory clinical efficacy and patient-reported outcomes from NOVA: A randomized controlled study of intravenous natalizumab 6-week dosing versus continued 4-week dosing for relapsing-remitting multiple sclerosis.
    Ryerson LZ; Foley JF; Defer G; Cohen JA; Arnold DL; Butzkueven H; Cutter G; Giovannoni G; Killestein J; Wiendl H; Sinks S; Kuhelj R; Bodhinathan K; Lasky T
    Mult Scler Relat Disord; 2023 Apr; 72():104561. PubMed ID: 36931078
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitative Synthesis of Timed 25-Foot Walk Performance in Multiple Sclerosis.
    Sikes EM; Cederberg KL; Sandroff BM; Bartolucci A; Motl RW
    Arch Phys Med Rehabil; 2020 Mar; 101(3):524-534. PubMed ID: 31669296
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern.
    Zörner B; Filli L; Reuter K; Kapitza S; Lörincz L; Sutter T; Weller D; Farkas M; Easthope CS; Czaplinski A; Weller M; Linnebank M
    Mult Scler; 2016 Oct; 22(11):1463-1475. PubMed ID: 26762672
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The clinical meaning of walking speed as measured by the timed 25-foot walk in patients with multiple sclerosis.
    Cohen JA; Krishnan AV; Goodman AD; Potts J; Wang P; Havrdova E; Polman C; Rudick RA
    JAMA Neurol; 2014 Nov; 71(11):1386-93. PubMed ID: 25178496
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of spasticity on mobility and balance in persons with multiple sclerosis.
    Sosnoff JJ; Gappmaier E; Frame A; Motl RW
    J Neurol Phys Ther; 2011 Sep; 35(3):129-32. PubMed ID: 21934374
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predicting falls in multiple sclerosis: Do electrophysiological measures have a better predictive accuracy compared to clinical measures?
    Chinnadurai SA; Gandhirajan D; Srinivasan AV; Kesavamurthy B; Ranganathan LN; Pamidimukkala V
    Mult Scler Relat Disord; 2018 Feb; 20():199-203. PubMed ID: 29414299
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The use of multi-domain patient reported outcome measures for detecting clinical disease progression in multiple sclerosis.
    van 't Hullenaar CAA; Coerver E; Kalkers NF; van Kempen Z; Koch M; Uitdehaag BMJ; Killestein J; Strijbis EMM
    Mult Scler Relat Disord; 2021 Oct; 55():103165. PubMed ID: 34404022
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A combined inspiratory and expiratory muscle training program improves respiratory muscle strength and fatigue in multiple sclerosis.
    Ray AD; Udhoji S; Mashtare TL; Fisher NM
    Arch Phys Med Rehabil; 2013 Oct; 94(10):1964-70. PubMed ID: 23714277
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gait assessment in shaped pathways: The test-retest reliability and concurrent validity of the figure of eight test and L test in multiple sclerosis patients without mobility aids.
    Özden F; Özkeskin M; Ar E; Yüceyar N
    Mult Scler Relat Disord; 2022 Sep; 65():103998. PubMed ID: 35777291
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Responsiveness and clinically meaningful improvement, according to disability level, of five walking measures after rehabilitation in multiple sclerosis: a European multicenter study.
    Baert I; Freeman J; Smedal T; Dalgas U; Romberg A; Kalron A; Conyers H; Elorriaga I; Gebara B; Gumse J; Heric A; Jensen E; Jones K; Knuts K; Maertens de Noordhout B; Martic A; Normann B; Eijnde BO; Rasova K; Santoyo Medina C; Truyens V; Wens I; Feys P
    Neurorehabil Neural Repair; 2014 Sep; 28(7):621-31. PubMed ID: 24503204
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of exercise training in adults with multiple sclerosis with severe mobility disability: A systematic review and future research directions.
    Edwards T; Pilutti LA
    Mult Scler Relat Disord; 2017 Aug; 16():31-39. PubMed ID: 28755682
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of Robotic Exoskeleton-Aided Gait Training in the Strength, Body Balance, and Walking Speed in Individuals With Multiple Sclerosis: A Single-Group Preliminary Study.
    Drużbicki M; Guzik A; Przysada G; Phd LP; Brzozowska-Magoń A; Cygoń K; Boczula G; Bartosik-Psujek H
    Arch Phys Med Rehabil; 2021 Feb; 102(2):175-184. PubMed ID: 33181115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.